研究業績
2024年英文論文
- Pituitary gland agouti-related peptide cells: Novel player controlling glucose metabolism
- Kei Takahashi, Hideki Katagiri
- J Diabetes Investig. 15(1): 67-69. 2024 Jan
- Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
- EMPA-KIDNEY Collaborative Group
- Lancet Diabetes Endocrinol. 12(1): 39-50. 2024 Jan
- Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
- EMPA-KIDNEY Collaborative Group
- Lancet Diabetes Endocrinol. 12(1): 51-60. 2024 Jan
- Stealthy progression of type 2 diabetes mellitus due to impaired ketone production in an adult patient with multiple acyl-CoA dehydrogenase deficiency
- Nodoka Ikeda, Yoichi Wada, Tomohito Izumi, Yuichiro Munakata, Hideki Katagiri, Shigeo Kure
- Mol Genet Metab Rep. 38: 101061. 2024 Jan 26
- A newly identified compound activating UCP1 inhibits obesity and its related metabolic disorders
- Ken Onodera, Yutaka Hasegawa, Nozomi Yokota, Shukuko Tamura, Hirofumi Kinno, Iwao Takahashi, Hiraku Chiba, Hirotatsu Kojima, Hideki Katagiri, Koji Nata, Yasushi Ishigaki
- Obesity (Silver Spring). 32(2): 324-338. 2024 Feb
- A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01)
- Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
- Diabetes Ther. 15(2): 533-545. 2024 Feb
- Screening Cutoff Values for the Detection of Aldosterone-Producing Adenoma by LC-MS/MS and a Novel Noncompetitive CLEIA
- Yoshikiyo Ono, Yuta Tezuka, Kei Omata, Ryo Morimoto, Yuto Yamazaki, Sota Oguro, Kei Takase, Akihiro Ito, Tatsunari Yoshimi, Satoshi Kojima, Sadayoshi Ito, Hironobu Sasano, Takashi Suzuki, Tetsuhiro Tanaka, Hideki Katagiri, Fumitoshi Satoh
- J Endocr Soc. 8(6): bvae080. 2024 Apr 20
- Investigating the cut-off values of captopril challenge test for primary aldosteronism using the novel chemiluminescent enzyme immunoassay method: a retrospective cohort study
- Yuta Tezuka, Kei Omata, Yoshikiyo Ono, Kengo Kambara, Hiroki Kamada, Sota Oguro, Yuto Yamazaki, Celso E Gomez-Sanchez, Akihiro Ito, Hironobu Sasano, Kei Takase, Tetsuhiro Tanaka, Hideki Katagiri, Fumitoshi Satoh
- Hypertens Res. 47(5): 1362-1371. 2024 May
- Optogenetic stimulation of vagal nerves for enhanced glucose-stimulated insulin secretion and β cell proliferation
- Yohei Kawana, Junta Imai, Yosuke M. Morizawa, Yoko Ikoma, Masato Kohata, Hiroshi Komamura, Toshihiro Sato, Tomohito Izumi, Junpei Yamamoto, Akira Endo, Hiroto Sugawara, Haremaru Kubo, Shinichiro Hosaka, Yuichiro Munakata, Yoichiro Asai, Shinjiro Kodama, Kei Takahashi, Keizo Kaneko, Shojiro Sawada, Tetsuya Yamada, Akira Ito, Kuniyasu Niizuma, Teiji Tominaga, Akihiro Yamanaka, Ko Matsui, Hideki Katagiri
- Nat Biomed Eng. 8(7): 808-822. 2024 Jul
- Possible etiological role of impaired endogenous double strand RNA editing in β-cells in type 1 diabetes
- Junta Imai
- J Diabetes Investig. 15(9): 1171-1173. 2024 Sep
- A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02)
- Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa
- J Diabetes Investig. 15(9): 1211-1219. 2024 Sep
- Inter-Organ Communication Involved in Brown Adipose Tissue Thermogenesis
- Kei Takahashi, Tetsuya Yamada, Hideki Katagiri
- Adv Exp Med Biol. 1461: 161-175. 2024 Sep
- Machine learning-based reproducible prediction of type 2 diabetes subtypes
- Hayato Tanabe, Masahiro Sato, Akimitsu Miyake, Yoshinori Shimajiri, Takafumi Ojima, Akira Narita, Haruka Saito, Kenichi Tanaka, Hiroaki Masuzaki, Junichiro J Kazama, Hideki Katagiri, Gen Tamiya, Eiryo Kawakami, Michio Shimabukuro
- Diabetologia. 67(11): 2446-2458. 2024 Nov
2024年その他論文・雑誌等
- 第44回日本肥満学会の報告
- 片桐秀樹
- 日本肥満学会誌. 30(1): 11-12
- 肥満時の代償性膵β細胞反応を制御する臓器間神経ネットワーク
- 今井淳太
- 日本肥満学会誌. 30(1): 20-25
- 生体内における標的細胞の増殖をリアルタイムかつ高感度に定量する手法
- 菅原裕人、今井淳太、片桐秀樹
- 実験医学. 42(13): 2087-2093
- 膵臓選択的な迷走神経刺激による膵β細胞増殖誘導
- 今井淳太
- Diabetes Journal. 51(3): 32-33
